Protein and Muscle on Weight-Loss Jabs: What Actually Helps

Why weight loss includes some muscle at all

Whenever the body loses a large amount of weight — through dieting, weight-loss surgery or GLP-1 jabs — some of that loss is lean tissue, not only fat. GLP-1 medicines are not thought to attack muscle directly; the muscle change is largely an indirect result of eating less and losing weight quickly: when you eat less overall, it is easy to fall short of the protein your body needs to hold on to muscle. In short, this is largely a feature of rapid weight loss in general, not a unique toxic effect of the drug — which is exactly why nutrition and exercise can push back against it.

What the trials actually found

Two large trials measured body composition with DEXA scans:

These numbers sound high, but two cautions apply. First, DEXA and similar scans carry a measurement error of roughly 10–15% on lean mass, so any single percentage is approximate. Second, "lean mass" is not the same as "muscle": it also includes water and other tissue, and some early loss is fluid. Importantly, in the SURMOUNT-1 substudy the roughly 25% lean / 75% fat split was similar to the placebo group — i.e. broadly what happens with weight loss in general.

Protein: how much, and how to actually hit it

Protein is the nutritional lever with the most evidence for preserving muscle during weight loss. Research in people losing weight generally points to protein intakes in the region of 1.2–1.6 g per kilogram of body weight per day, spread across meals, with some studies suggesting higher intakes help when muscle retention matters most. But the right target depends on your age, kidney health and other conditions — high protein is not safe for everyone, particularly with reduced kidney function — so ask your GP, pharmacist or a dietitian for a figure that is right for you.

The bigger practical problem on a GLP-1 jab is often getting the protein in. Appetite is suppressed, portions shrink, and nausea can peak in the days after a dose. A few things help:

• Eat protein first at each meal, while your appetite is at its best — eggs, fish, chicken, dairy, beans, lentils, tofu.
• Spread it across the day rather than one big evening meal, so your body gets a steady supply.
• Lean on easier-to-tolerate options when nausea is bad — Greek yoghurt, milk, or a protein drink can be gentler than a large solid meal. Plant proteins tend to be lower in the key amino acids, so you generally need a bit more of them.
• Keep meals small and frequent if fullness hits early, and stay hydrated.

Strength training: the other half of the answer

Protein gives your body the raw material; resistance (strength) exercise gives it the signal to keep muscle rather than break it down. This is the single most effective non-drug way to protect lean mass during weight loss. You don't need a gym: bodyweight moves, resistance bands, or everyday "lift and carry" activity all count.

• Aim for strength work at least twice a week, covering the major muscle groups (legs, hips, back, chest, shoulders, arms) — the NHS has free strength and flexibility guidance.
• Build gradually and pair it with adequate protein — the two work together.
• If you have a heart condition, joint problems or haven't exercised in a while, check with your GP or a physiotherapist before starting.

Who is most at risk of losing too much muscle?

• Older adults (roughly 60 and over), who have less muscle to start with and rebuild it more slowly.
• People with already-low muscle mass or "sarcopenic obesity" (low muscle alongside excess fat).
• Anyone losing weight very fast or eating very little protein.

If any of these apply to you, it is worth raising muscle and bone health with your clinician before or soon after starting a GLP-1 jab, so exercise and nutrition can be built in from the start.

Do the different jabs differ — and what about the newer ones?

You may have read that tirzepatide (Mounjaro) causes more muscle loss than semaglutide (Wegovy). There is no head-to-head randomised trial confirming a real difference, and tirzepatide also tends to produce more total weight loss, which changes any comparison. The practical advice — protein plus strength training — is the same for both. Newer agents in development, such as the triple-hormone agent retatrutide (which is investigational and not licensed in the UK), add a glucagon action that could in theory increase protein turnover, but this is a theoretical concern that has not been quantified in patients. You can read our status pages on Mounjaro in the UK, Wegovy and Ozempic, the oral GLP-1 orforglipron and retatrutide for where each currently stands.

Are there medicines to prevent muscle loss?

This is an active research area, but the honest answer for UK patients is: not yet. Several muscle-preserving drugs are being tested alongside GLP-1 medicines in clinical trials — for example bimagrumab and trevogrumab, antibodies that block muscle-limiting signalling. In phase 2 trials, adding these agents to semaglutide preserved a meaningful share of the lean mass that would otherwise have been lost while fat loss continued. But as of July 2026 they are investigational only: they are not licensed or available for this use in the UK, and their long-term safety and benefit are still being established. Be very cautious of anyone marketing "muscle-preserving" peptides, injectables or drugs for weight loss online — that is not a recognised or safe route, and it sits outside regulated UK supply.

Related reading